PhylloPharma

Headquarters

Unknown, US

PhylloPharma is developing oral delivery systems for protein drugs through encapsulation in plant cells, addressing challenges of traditional sterile injections and cold storage. The company's platform targets viral disease treatments including SARS-CoV-2, Influenza, CMV, EBV, Hepatitis C, and Herpes viruses.

• Nanobrid Innovations Private LimitedNanobrid Innovations Private Limited is a pharmaceutical manufacturing company that develops a proprietary next-generation lipid-polymer hybrid nanotechnology platform. The platform enables delivery of difficult-to-deliver active ingredients across various therapeutic areas and clinical indications, with flexibility for multiple routes of administration such as topical, injectables, ocular, and nasal.RAJASTHAN, IN
• ARxARx is a full-service partner for pharmaceutical and biopharma companies specializing in developing novel drug delivery systems through Oral Thin Films and Transdermal Patches. The company manufactures dissolvable films and patches to improve control, bioavailability, and patient experience.GLEN ROCK, PA
• Lipella Pharmaceuticals IncLipella Pharmaceuticals Inc. is a clinical-stage pharmaceutical company developing liposomal drug formulations for mucosal delivery, focusing on rare diseases and oncology support. The company's pipeline includes treatments for oral lichen planus, hemorrhagic cystitis, oral graft-versus-host disease, and non-muscle invasive bladder cancer.PITTSBURGH, PA
• AmpulisAmpulis develops and manufactures drug delivery solutions, specifically the Pristal and Flowen platforms for lyophilized and liquid formulations, respectively. The company focuses on creating user-focused, reliable devices to accelerate patient access to life-saving treatments.BERWYN, PA